ZIKV E Antikörper

Produktnummer ABIN7383929

Produktdetails anti-ZIKV E Antikörper

Target: ZIKV E (Zika Virus Envelope (ZIKV E))

Reaktivität: Zika Virus (ZIKV)

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser ZIKV E Antikörper ist unkonjugiert

Applikation: ELISA

Spezifität: Anti-Zika virus(ZIKV)(strain Zika SPH2015) ZIKV-E/Envelope protein Monoclonal Antibody

Aufreinigung: Protein A Affinity

Immunogen: Recombinant ZIKV (strain Zika SPH2015) Envelope protein (Domain III, His Tag), ABIN7198753

Klon: 35

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ELISA 1:1000-1:10000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1 mg/mL

Buffer: 0.2 μm filtered solution in PBS

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Details zu ZIKV E

Target: ZIKV E (Zika Virus Envelope (ZIKV E))

Andere Bezeichnung: ZIKV Envelope Protein (ZIKV E Produkte)

Hintergrund: E,Envelope Protein,Envelope of Zika virus is resposible for receptor binding and membrane. Analysis of the envelope protein of Zika, from Brazilian Zika SPH215 (KU321639), indicates predicted B and T cell epitopes in peptides that are consistent to those reported for dengue, YFYF and Japanese encephalitis. The envelope Domain II B cell epitope, to which much dengue non-neutralizing cross reaction is attributed, is also conserved also in Zika virus, consistent with prior field observations of cross reactivity with dengue and YF. Domain III of the Zika envelope protein, likely the main specific neutralizing domain, is distinct from recent Brazilian dengue isolates and a recent Peruvian YF isolate (GQ379163), 76 % of possible major histocompatibility complex class (MHC) I and MHC II binding peptides and potential B cell linear epitopes are unique to Zika virus.